Skip to main content
FinSpry Logo
FinSpry
VRDN logo
VRDN
(NASDAQ)
Viridian Therapeutics, Inc.
$19.26-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Viridian Therapeutics, Inc. (VRDN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Viridian Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 13 professional research analysts

Consensus Rating

Buy
Based on 13 unique analysts
(23 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$32.91
↑ 70.87% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest VRDN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Alex Thompson CFA
Stifel Nicolaus
BuyMaintains
$39.00 → $40.00
Gregory Renza
Truist
BuyMaintains
$35.00 → $38.00
Faisal Khurshid
Jefferies
BuyMaintains
$30.00
Lisa Walter
RBC Capital
BuyMaintains
$34.00 → $35.00
Rami Katkhuda
LifeSci Capital
BuyReiterates
$50.00 → $35.00
Douglas Tsao
HC Wainwright
BuyReiterates
$22.00
Lachlan Hanbury Brown
William Blair
BuyMaintains
-
Gregory Renza
Truist
BuyMaintains
$35.00 → $38.00
Richard Law CFA
Goldman Sachs
BuyReiterates
$35.00 → $39.00
Derek Archila
Wells Fargo
BuyUpgrades
$20.00 → $31.00
Serge Belanger
Needham
BuyMaintains
$32.00 → $34.00
Lisa Walter
RBC Capital
BuyMaintains
$34.00 → $35.00
Gavin Clark-Gartner
Evercore ISI Group
BuyMaintains
$27.00 → $26.00
Alex Thompson CFA
Stifel Nicolaus
BuyMaintains
$48.00 → $39.00
Rami Katkhuda
LifeSci Capital
BuyMaintains
$35.00
Rami Katkhuda
LifeSci Capital
BuyMaintains
$35.00
Douglas Tsao
HC Wainwright
BuyReiterates
$1.00 → $22.00
Gregory Renza
Truist
BuyMaintains
$33.00 → $35.00
Lisa Walter
RBC Capital
BuyReiterates
$30.00 → $34.00
Laura Chico
Wedbush
BuyMaintains
$31.00 → $32.00
Lachlan Hanbury Brown
William Blair
BuyMaintains
-
Joseph Thome
TD Cowen
BuyMaintains
-
Serge Belanger
Needham
BuyMaintains
$32.00

Frequently Asked Questions

What is the analyst consensus rating for VRDN?

The analyst consensus rating for VRDN is "Buy" based on 13 analyst recommendations.

What is the average price target for VRDN?

The average 12-month price target for VRDN is $32.91, representing an upside of 70.9% from the current price of $19.26.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.